Dipartimento di Farmacia, University of Pisa, Via Bonanno 6/33, 56126 Pisa, Italy.
Dipartimento di Scienze del Farmaco, University of Piemonte Orientale Amedeo Avogadro, Largo Donegani 2, 28100 Novara, Italy.
Molecules. 2019 Sep 19;24(18):3414. doi: 10.3390/molecules24183414.
Zwitterionic polysaccharides (ZPs) have been shown in recent years to display peculiar immunological properties, thus attracting the interest of the carbohydrate research community. To fully elucidate the mechanisms underlying these properties and exploit the potential of this kind of structures, in depth studies are still required. In this context, the preparation of two cationic, an anionic, as well as two zwitterionic tetrasaccharide analogues of the smallest immunogenic structure of type 14 (SP14) capsular polysaccharide are presented. By exploiting a block strategy, the negative charge has been installed on the non-reducing end of the lactose unit of the tetrasaccharide and the positive charge either on the non-reducing end of the lactosamine moiety or on an external linker. These structures have then been tested by competitive ELISA, showing that the structural variations we made do not modify the affinity of the neutral compound to binding to a specific antibody. However, lower efficacies than the natural SP14 compound were observed. The results obtained, although promising, point to the need to further elongate the polysaccharide structure, which is likely too short to cover the entire epitopes.
近年来,两性离子多糖(ZPs)表现出独特的免疫学特性,引起了碳水化合物研究界的兴趣。为了充分阐明这些特性的机制并挖掘这种结构的潜力,仍需要深入研究。在这种情况下,本文制备了两种阳离子、一种阴离子以及两种十四型(SP14)荚膜多糖最小免疫结构的四糖类似物。通过利用块策略,将负电荷安装在四糖乳糖单元的非还原端,而正电荷则位于乳糖胺部分的非还原端或外部连接子上。通过竞争性 ELISA 对这些结构进行了测试,结果表明,我们所做的结构变化不会改变中性化合物与特定抗体结合的亲和力。然而,与天然 SP14 化合物相比,观察到的功效较低。尽管取得了有希望的结果,但这些结果表明需要进一步延长多糖结构,因为它可能太短而无法覆盖整个表位。